EK

Elisha Kolakaluri

Active Director Director DIN 11576952
DIN 11576952 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Elisha Kolakaluri

Data last updated:

Elisha Kolakaluri is a Director at Regalo Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11576952
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20262026Active

Board colleagues of Elisha Kolakaluri

NameDINCompanyDesignation
Hima Bindu Dukkipati11576953Regalo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Regalo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Elisha Kolakaluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elisha Kolakaluri

Elisha Kolakaluri currently holds 1 directorship: Regalo Pharmaceuticals Private Limited (Director, since 27 Feb 2026).

Elisha Kolakaluri was first appointed on 27 Feb 2026 as Director at Regalo Pharmaceuticals Private Limited.

The current boards of Elisha Kolakaluri's companies include Hima Bindu Dukkipati (Regalo Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available